Avid Bioservices Inc - CDMO Sales Growth YoY (Last Twelve Months)

Public company logo of Avid Bioservices Inc (CDMO)

The rolling 12-month sales growth versus the previous year shows that the metric has leveled off at 5.10. Avid Bioservices, Inc. (CDMO) minimizes risks by providing contract drug manufacturing for various pharmaceutical partners. The robotization of lines with AI control eliminates contamination and accelerates testing. Simultaneously, the company is implementing water recycling and transitioning to renewable energy to reduce hazardous waste.

Sales Growth YoY (TTM): Avid Bioservices Inc (CDMO) for 02/11/2024 - 02/20/2024

Avid Bioservices (CDMO) - metric breakdowns and financial figures

- market price and analyst price targets:
Summary company analytics:CDMO Avid Bioservices Inc
Brand item of avidbio.com

Avid Bioservices, Inc. (CDMO) serves as a high-tech manufacturing hub, providing pharma behemoths with the engineering infrastructure required for the synthesis of complex antibodies. Analyzing the 12-month year-over-year revenue trends allows for a daily assessment of the business's scaling dynamics, revealing the company's ability to outpace cost inflation, provided that sales expansion is accompanied by a proportional increase in net profit.